Alternative genotyping method of GSTT1 null/present polymorphism.

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Glutathione S-transferase (GST) theta enzymes detoxify xenobiotics.
• The GSTT1 gene exhibits a null/present polymorphism, crucial for cancer susceptibility research.
• Existing methods for distinguishing GSTT1 genotypes are limited by the complexity of long DNA sequencing.

Purpose of the Study:

• To develop and validate an alternative PCR-based genotyping method for the GSTT1 null/present polymorphism.
• To enable accurate differentiation of null, heterozygous, and homozygous GSTT1 genotypes.
• To facilitate future research on cancer susceptibility linked to GSTT1 variations.

Main Methods:

• Utilized typical PCR primers specific to the null allele (566 bp) and present allele (458 bp).
• Applied the new PCR method to genotype 700+ human samples.
• Validated the PCR method against a conventional genotyping technique.

Main Results:

• The novel PCR method accurately classified all tested GSTT1 null (n=331), heterozygous (n=364), and homozygous (n=108) genotypes.
• The method demonstrated high concordance with conventional genotyping.
• Successfully genotyped long DNA sequences (1460 bp) previously challenging.

Conclusions:

• The developed PCR method is a reliable and efficient tool for GSTT1 null/present polymorphism genotyping.
• This method is suitable for large-scale research, including cancer susceptibility studies.
• The ability to accurately classify all three genotypes (null, heterozygous, homozygous) is critical for future research.